Literature DB >> 23055892

Vancomycin dosage regimens for pediatric patients.

Milap C Nahata1.   

Abstract

Entities:  

Keywords:  children; dosage regimens; infants; serum concentration; vancomycin

Year:  2009        PMID： 23055892      PMCID： PMC3461979          DOI： 10.5863/1551-6776-14.2.64

Source DB:  PubMed          Journal:  J Pediatr Pharmacol Ther        ISSN： 1551-6776


× No keyword cloud information.
  9 in total

1.  Guidelines for the management of adults with hospital-acquired, ventilator-associated, and healthcare-associated pneumonia.

Authors: 
Journal:  Am J Respir Crit Care Med       Date:  2005-02-15       Impact factor: 21.405

2.  Evidence for reduction in breakpoints used to determine vancomycin susceptibility in Staphylococcus aureus.

Authors:  Mandy Wootton; T R Walsh; A P MacGowan
Journal:  Antimicrob Agents Chemother       Date:  2005-09       Impact factor: 5.191

3.  High-dose vancomycin therapy for methicillin-resistant Staphylococcus aureus infections: efficacy and toxicity.

Authors:  Levita K Hidayat; Donald I Hsu; Ryan Quist; Kimberly A Shriner; Annie Wong-Beringer
Journal:  Arch Intern Med       Date:  2006-10-23

4.  Correlation of vancomycin dosing to serum concentrations in pediatric patients: a retrospective database review.

Authors:  Kim W Benner; Mary A Worthington; David W Kimberlin; Kim Hill; Kevin Buckley; Nancy M Tofil
Journal:  J Pediatr Pharmacol Ther       Date:  2009-04

5.  Lack of vancomycin-associated nephrotoxicity in newborn infants: a case-control study.

Authors:  V Bhatt-Mehta; R E Schumacher; R G Faix; M Leady; T Brenner
Journal:  Pediatrics       Date:  1999-04       Impact factor: 7.124

6.  Influence of vancomycin minimum inhibitory concentration on the treatment of methicillin-resistant Staphylococcus aureus bacteremia.

Authors:  Alex Soriano; Francesc Marco; José A Martínez; Elena Pisos; Manel Almela; Veselka P Dimova; Dolores Alamo; Mar Ortega; Josefina Lopez; Josep Mensa
Journal:  Clin Infect Dis       Date:  2008-01-15       Impact factor: 9.079

7.  Relationship of MIC and bactericidal activity to efficacy of vancomycin for treatment of methicillin-resistant Staphylococcus aureus bacteremia.

Authors:  George Sakoulas; Pamela A Moise-Broder; Jerome Schentag; Alan Forrest; Robert C Moellering; George M Eliopoulos
Journal:  J Clin Microbiol       Date:  2004-06       Impact factor: 5.948

8.  Lack of nephrotoxicity in pediatric patients receiving concurrent vancomycin and aminoglycoside therapy.

Authors:  M C Nahata
Journal:  Chemotherapy       Date:  1987       Impact factor: 2.544

9.  Clinical efficacy of therapeutic drug monitoring in patients receiving vancomycin.

Authors:  Takuya Iwamoto; Yoshiyuki Kagawa; Michio Kojima
Journal:  Biol Pharm Bull       Date:  2003-06       Impact factor: 2.233
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.